Shandong Weigao Medical Polymer Current Ratio 2012-2024 | SHWGF
Shandong Weigao Medical Polymer current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Shandong Weigao Medical Polymer Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $2.70B | $0.82B | 3.28 |
| 2014-06-30 | $1.01B | $0.34B | 2.96 |
| 2013-12-31 | $1.01B | $0.34B | 3.00 |
| 2013-06-30 | $0.66B | $0.27B | 2.41 |
| 2012-12-31 | $0.61B | $0.24B | 2.53 |
| 2012-06-30 | $0.63B | $0.20B | 3.17 |
| 2011-12-31 | $0.60B | $0.17B | 3.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.828B | 25.79 |
| Boston Scientific (BSX) | United States | $156.585B | 37.40 |
| Stryker (SYK) | United States | $152.939B | 31.98 |
| EssilorLuxottica (ESLOY) | France | $137.925B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.343B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.576B | 24.87 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.596B | 16.90 |
| Agilent Technologies (A) | United States | $33.957B | 22.14 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $24.709B | 17.34 |
| Insulet (PODD) | United States | $20.568B | 80.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.989B | 12.20 |
| Baxter (BAX) | United States | $14.636B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.656B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.891B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $5.010B | 12.64 |
| Perrigo (PRGO) | Ireland | $3.867B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.770B | 16.84 |
| Haemonetics (HAE) | United States | $3.587B | 16.34 |
| Envista Holdings (NVST) | United States | $3.515B | 29.21 |
| ICU Medical (ICUI) | United States | $3.138B | 23.14 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| QuidelOrtho (QDEL) | United States | $1.764B | 12.14 |
| AtriCure (ATRC) | United States | $1.645B | 0.00 |
| Acuren (TIC) | United States | $1.367B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.96 |
| AdaptHealth (AHCO) | United States | $1.294B | 13.14 |
| Neogen (NEOG) | United States | $1.176B | 15.06 |
| Phibro Animal Health (PAHC) | United States | $1.172B | 14.98 |
| BioLife Solutions (BLFS) | United States | $1.063B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.987B | 0.00 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| Valneva SE (VALN) | France | $0.648B | 0.00 |
| Owens & Minor (OMI) | United States | $0.608B | 5.04 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| CeriBell (CBLL) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.524B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.82 |
| SNDL (SNDL) | Canada | $0.394B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.358B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.97 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.310B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.306B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 79.67 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.246B | 20.77 |
| Biote (BTMD) | United States | $0.239B | 6.72 |
| Verano Holdings (VRNOF) | United States | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.227B | 60.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.45 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.83 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Apyx Medical (APYX) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.38 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |